Proactive Investors - Run By Investors For Investors

Imugene gets ready to raise

Imugene Ltd (ASX:IMU) has been granted a trading halt by the ASX, pending details of a capital raising.
Imugene gets ready to raise
Imugene in a trading halt

The halt will remain in place until the opening of trade on Friday 21st October 2016, or earlier if an announcement is made to the market.

View full IMU profile View Profile

Imugene Ltd Timeline

Newswire
October 19 2016

Related Articles

immunotherapy graphic
September 13 2018
A clinical trial application for the potential cancer treatment is on track to be filed in the current quarter, and that will be followed by patient recruitment towards the end of the year
Collagen testing
August 17 2018
Since reporting its full-year results on July 10, the AIM-listed shares have rallied over 38% in the past month to 3.65p currently, taking year-to-date gains to a third
pills
January 15 2019
Under former chief executive Peter George and his successor Shaun Chilton, Clinigen has been transformed via a series of well-judged, quickly integrated and cash generative acquisitions

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use